Lung Cancer

New app measures the risk of chronic diseases

Globally, cardiovascular diseases, diabetes and cancer are responsible for thousands of deaths a year in economically active population. Such problems led to a Mexican scientific team to develop a virtual ...

May 06, 2014
popularity not rated yet | comments 0

Q&A: Cancer care in crisis

Almost daily, consumers hear about new advances in the treatment of cancer: a new drug, dazzling technological achievements or eye-opening scientific discoveries. Why, then, are some of the nation's foremost ...

May 01, 2014
popularity not rated yet | comments 0

Modafinil doesn't improve NSCLC-related fatigue

(HealthDay)—The central nervous system stimulant modafinil is not effective in treating non-small-cell lung cancer-related fatigue, according to a study published online April 28 in the Journal of Clinical On ...

Apr 30, 2014
popularity not rated yet | comments 0

Vitamin D may raise survival rates among cancer patients

Cancer patients who have higher levels of vitamin D when they are diagnosed tend to have better survival rates and remain in remission longer than patients who are vitamin D-deficient, according to a new study published in ...

Apr 29, 2014
popularity 5 / 5 (2) | comments 0

Latest Spotlight News

Study reveals nervous system's role in asthma attacks

(Medical Xpress)—Asthma is a debilitating condition that kills 250,000 people around the world each year. People with asthma have hyperreactive airways and thickened lung walls obstructed with mucus. During ...

Researchers discover neuroprotective role of immune cell

A type of immune cell widely believed to exacerbate chronic adult brain diseases, such as Alzheimer's disease and multiple sclerosis (MS), can actually protect the brain from traumatic brain injury (TBI) and may slow the ...

Molecular basis of age-related memory loss explained

From telephone numbers to foreign vocabulary, our brains hold a seemingly endless supply of information. However, as we are getting older, our ability to learn and remember new things declines. A team of ...